A. Donson

发表

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

David T. W. Jones, V. P. Collins, M. Wolter, 2012, Cancer cell.

Protein Kinase C ζ Isoform is Critical for Proliferation in Human Glioblastoma Cell Lines

A. Banerjee, F. Gamboni-Robertson, A. Donson, 2000, Journal of Neuro-Oncology.

Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.

Gary D Bader, David T. W. Jones, V. P. Collins, 2015, Cancer cell.

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations

Michael Brudno, Jennifer Chan, Uri Tabori, 2014, Nature Genetics.

Single-Cell RNA Sequencing of Childhood Ependymoma Reveals Neoplastic Cell Subpopulations That Impact Molecular Classification and Etiology.

Austin E. Gillen, Eric W Prince, J. Hesselberth, 2020, Cell reports.

Cytotoxicity of glioblastoma cells mediated ex vivo by varicella-zoster virus-specific T cells

A. Donson, N. Foreman, A. Weinberg, 2011, Journal of NeuroVirology.

Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B

David C. Jones, S. Pfister, A. von Deimling, 2021, Nature Communications.

SOX10 Distinguishes Pilocytic and Pilomyxoid Astrocytomas From Ependymomas but Shows No Differences in Expression Level in Ependymomas From Infants Versus Older Children or Among Molecular Subgroups

T. Tihan, B. Kleinschmidt-DeMasters, M. Pekmezci, 2016, Journal of neuropathology and experimental neurology.

Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity

A. Thorburn, A. Donson, N. Foreman, 2010, Molecular Cancer Therapeutics.

Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors.

A. Thorburn, D. Mirsky, V. Amani, 2014, Cancer discovery.

Title: Autophagy Inhibition Improves Chemosensitivity in BRAF Brain Tumors

A. Thorburn, D. Mirsky, A. Donson, 2014 .

Neoplastic and immune single cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma

J. Hesselberth, M. Sill, R. Wechsler-Reya, 2020, bioRxiv.

A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high‐grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study

T. MacDonald, I. Ostrovnaya, M. Kieran, 2017, Pediatric blood & cancer.

Diffuse intrinsic pontine tumors: a study of primitive neuroectodermal tumors versus the more common diffuse intrinsic pontine gliomas.

A. Donson, N. Foreman, P. Jedlicka, 2012, Journal of neurosurgery. Pediatrics.

Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target

David T. W. Jones, H. Williams, J. Martinez-Barbera, 2018, Acta Neuropathologica.

Preclinical high‐dose acetaminophen with N‐acetylcysteine rescue enhances the efficacy of cisplatin chemotherapy in atypical teratoid rhabdoid tumors

E. Neuwelt, V. Amani, R. Vibhakar, 2014, Pediatric blood & cancer.

MiR‐1253 exerts tumor‐suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7‐H3)

S. Batra, M. Snuderl, D. Boue, 2020, Brain pathology.

In vitro benchmarking of NF-κB inhibitors.

Noah E. Berlow, C. Keller, W. Zuercher, 2020, European journal of pharmacology.

MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma

A. Donson, N. Foreman, M. Handler, 2007, Pediatric blood & cancer.

Targetable molecular alterations in congenital glioblastoma

K. Davies, B. Kleinschmidt-DeMasters, A. Donson, 2019, Journal of Neuro-Oncology.

Targeting IL-6 Is a Potential Treatment for Primary Cystic Craniopharyngioma

D. Mirsky, A. Donson, N. Foreman, 2019, Front. Oncol..

Gefitinib is effective against juvenile pilocytic astrocytoma in vitro

A. Donson, N. Foreman, R. Heideman, 2006, Pediatric blood & cancer.

NF-&kgr;B upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymoma

Kenneth L. Jones, R. Vibhakar, A. Donson, 2017, Neuro-oncology.

Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells

R. Vibhakar, A. Donson, N. Foreman, 2012, Journal of Neuro-Oncology.

Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma.

Eric W Prince, Kenneth L. Jones, S. Karam, 2019, Neuro-oncology.

MPS1 kinase as a potential therapeutic target in medulloblastoma

Michael D. Taylor, R. Vibhakar, A. Donson, 2016, Oncology reports.

Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells

Michael D. Taylor, A. Dubuc, R. Vibhakar, 2012, BMC Cancer.

Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma

V. Amani, R. Vibhakar, A. Donson, 2016, BMC Cancer.

Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma

S. Karam, C. Albanese, R. Vibhakar, 2017, Cancer Cell International.

Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors

Eric W Prince, K. Davies, B. Kleinschmidt-DeMasters, 2020, Pediatric blood & cancer.

Targeting Polo-like kinase 1 in SMARCB1 deleted atypical teratoid rhabdoid tumor

Eric W Prince, M. Kool, A. Pierce, 2017, Oncotarget.

Molecular array analyses of 51 pediatric tumors shows overlap between malignant intracranial ectomesenchymoma and MPNST but not medulloblastoma or atypical teratoid rhabdoid tumor

M. Lovell, K. Lillehei, B. Kleinschmidt-DeMasters, 2007, Acta Neuropathologica.

Pilomyxoid Astrocytoma (PMA) Shows Significant Differences in Gene Expression vs. Pilocytic Astrocytoma (PA) and Variable Tendency Toward Maturation to PA

H. Vogel, B. Kleinschmidt-DeMasters, A. Donson, 2015, Brain pathology.

Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells

R. Vibhakar, A. Donson, N. Foreman, 2012, Journal of Neuro-Oncology.

Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation.

K. Davies, A. Donson, Jean M. Mulcahy Levy, 2021, Journal of neuropathology and experimental neurology.

Desmoplastic infantile astrocytoma/ganglioglioma with rare BRAF V600D mutation

K. Davies, B. Kleinschmidt-DeMasters, A. Donson, 2017, Pediatric blood & cancer.

CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy

R. LaRue, C. Moertel, H. Okada, 2014, Journal of Immunotherapy for Cancer.

Measurement of Tamoxifen-Induced Apoptosis in Glioblastoma by Cytometric Bead Analysis of Active Caspase-3

A. Donson, N. Foreman, J. Fleitz, 2004, Journal of Neuro-Oncology.

Immunotherapeutic implications of the immunophenotype of pediatric brain tumors

A. Donson, N. Foreman, A. Griesinger, 2014, Oncoimmunology.

This information is current as Tumor Types Immunophenotypes across Pediatric Brain Characterization of Distinct

V. Amani, A. Donson, N. Foreman, 2013 .

Ependymoma Associated with a Good Prognosis in Immune Gene and Cell Enrichment Is

B. Kleinschmidt-DeMasters, A. Donson, N. Foreman, 2009 .

Adenovirus Mediated Gene Therapy in a Glioblastoma Vaccine Model; Specific Antitumor Immunity and Abrogation of Immunosuppression

A. Donson, N. Foreman, 1998, Journal of Neuro-Oncology.

Inhibition of Aurora Kinase A enhances chemosensitivity of medulloblastoma cell lines

R. Vibhakar, A. Donson, N. Foreman, 2010, Pediatric blood & cancer.

Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG

Kenneth L. Jones, M. Monje, C. Hawkins, 2020, Cell Reports.

Emerging evidence of anti-tumor immune control in the central nervous system

A. Donson, N. Foreman, 2012, Oncoimmunology.

IMP3 Protein Expression is an Independent Prognostic Factor in Pediatric Pilocytic and Pilomyxoid Astrocytoma

A. Donson, N. Foreman, M. Handler, 2015 .

Insulin-like growth factor 2 mRNA binding protein 3 expression is an independent prognostic factor in pediatric pilocytic and pilomyxoid astrocytoma.

B. Kleinschmidt-DeMasters, A. Donson, N. Foreman, 2013, Journal of neuropathology and experimental neurology.

H3 K27M Mutation in Gangliogliomas can be Associated with Poor Prognosis

B. Kleinschmidt-DeMasters, A. Donson, N. Foreman, 2017, Brain pathology.

Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells

Michael D. Taylor, A. Dubuc, R. Vibhakar, 2012, BMC Cancer.

Glycation of Glutamate Cysteine Ligase by 2-Deoxy-d-Ribose and its Potential Impact on Chemoresistance in Glioblastoma

J. Kepa, D. Petersen, A. Donson, 2013, Neurochemical Research.

Characterization of Distinct Immunophenotypes across Pediatric Brain Tumor Types

V. Amani, A. Donson, N. Foreman, 2013, The Journal of Immunology.

Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors

A. Thorburn, K. Davies, D. Aisner, 2017, eLife.

Increased Immune Gene Expression and Immune Cell Infiltration in High-Grade Astrocytoma Distinguish Long-Term from Short-Term Survivors

B. Kleinschmidt-DeMasters, S. Schittone, A. Donson, 2012, The Journal of Immunology.

Clinical and molecular characteristics of congenital glioblastoma.

B. Kleinschmidt-DeMasters, A. Donson, N. Foreman, 2012, Neuro-oncology.

High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival.

B. Kleinschmidt-DeMasters, D. Ashley, Andrea M. Muscat, 2011, Neuro-oncology.

Aurora kinase A as a rational target for therapy in glioblastoma.

Michael H Handler, Andrew M Donson, R. Vibhakar, 2010, Journal of neurosurgery. Pediatrics.

HGG-17. PEDIATRIC RADIATION-INDUCED GLIOBLASTOMA: TRANSCRIPTOMIC AND DRUG SCREENING ANALYSIS OF PRIMARY PATIENT SAMPLES.

A. Donson, N. Foreman, Patrick C. Flannery, 2017 .

Unique Molecular Characteristics of Pediatric Myxopapillary Ependymoma

B. Kleinschmidt-DeMasters, A. Donson, N. Foreman, 2009, Brain pathology.

Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma

V. Amani, R. Vibhakar, A. Donson, 2015, Cancer Immunology Research.

Mapping pediatric brain tumors to their origins in the developing cerebellum

Mariella G. Filbin, Jennifer L. Hadley, David T. W. Jones, 2021, bioRxiv.

NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline Gliomas.

S. Baker, Dong Wang, R. Vibhakar, 2021, Journal of neuropathology and experimental neurology.

Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma

V. Amani, A. Donson, N. Foreman, 2014, Acta Neuropathologica.

A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy.

M. Erlander, S. Fosmire, Dong Wang, 2021, Neuro-oncology.

Targeting fibroblast growth factor receptors to combat aggressive ependymoma

Mariella G. Filbin, S. Spiegl-Kreinecker, D. Lötsch, 2021, Acta Neuropathologica.

Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma

Elliot A. Warner, V. Amani, R. Vibhakar, 2018, Molecular Cancer Therapeutics.

p16 Loss and E2F/cell cycle deregulation in infant posterior fossa ependymoma

Kenneth L. Jones, B. Kleinschmidt-DeMasters, R. Vibhakar, 2017, Pediatric blood & cancer.

Spatial transcriptomic analysis delineates epithelial and mesenchymal subpopulations and transition stages in childhood ependymoma.

K. Riemondy, V. Amani, S. Mitra, 2022, Neuro-oncology.

Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma

Sandro Santagata, Ziming Du, Shannon Coy, 2018, Neuro-oncology.

Inhibition of MYC attenuates tumor cell self‐renewal and promotes senescence in SMARCB1‐deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo

A. Pierce, L. Soucek, Etienne Danis, 2019, International journal of cancer.

Pediatric Brainstem Gangliogliomas Show BRAFV600E Mutation in a High Percentage of Cases

D. Aisner, B. Kleinschmidt-DeMasters, Amy A. Smith, 2014, Brain pathology.

Survey of MicroRNA expression in pediatric brain tumors

Michael H Handler, Andrew M Donson, R. Vibhakar, 2011, Pediatric blood & cancer.

Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma

T. Merchant, U. Schüller, G. Armstrong, 2021, Nature Communications.

Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma

T. Merchant, U. Schüller, G. Armstrong, 2021, Nature Communications.

Comprehensive molecular characterization of pediatric treatment-induced high-grade glioma: A distinct entity despite disparate etiologies with defining molecular characteristics and potential therapeutic targets

Kenneth L. Jones, T. Merchant, U. Schüller, 2019, bioRxiv.

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma

Michael D. Taylor, A. Dubuc, R. Vibhakar, 2014, Molecular Cancer.

Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma

K. Davies, V. Amani, A. Donson, 2020, Journal of Neuro-Oncology.

Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profile

Kirk Wilhelmsen, R. Vibhakar, A. Donson, 2021, Communications biology.

Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profile

Kirk Wilhelmsen, R. Vibhakar, A. Donson, 2020, Communications Biology.

EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY

Tina N. Davis, Forrest M Kievit, Atique U. Ahmed, 2013 .

Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes

B. Kleinschmidt-DeMasters, R. Vibhakar, A. Donson, 2013, Pediatric blood & cancer.

Histone deacetylase inhibition decreases proliferation and potentiates the effect of ionizing radiation in atypical teratoid/rhabdoid tumor cells.

R. Vibhakar, A. Donson, N. Foreman, 2012, Neuro-oncology.

Targeting the TP53/MDM2 axis enhances radiation sensitivity in atypical teratoid rhabdoid tumors

N. Serkova, Dong Wang, A. Pierce, 2022, International journal of oncology.

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma

Michael D. Taylor, A. Dubuc, R. Vibhakar, 2014, Molecular Cancer.

A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma

S. Fosmire, Dong Wang, A. Pierce, 2021, Cancers.

Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma

Eric W Prince, M. Remke, Michael D. Taylor, 2015, Oncotarget.

ATYPICAL TERATOID RHABDOID TUMOR (ATRT)

R. Siebert, K. Ligon, C. Roberts, 2012 .

Specific expression of PD‐L1 in RELA‐fusion supratentorial ependymoma: Implications for PD‐1‐targeted therapy

Kenneth L. Jones, V. Amani, A. Donson, 2018, Pediatric blood & cancer.

Immune Gene and Cell Enrichment Is Associated with a Good Prognosis in Ependymoma1

Nicholas K. Foreman, Michael H. Handler, B. Kleinschmidt-DeMasters, 2009, The Journal of Immunology.

Tamoxifen radiosensitization in human glioblastoma cell lines.

A. Donson, N. Foreman, N K Foreman, 1999, Journal of neurosurgery.

Pediatric brainstem gangliogliomas show overexpression of neuropeptide prepronociceptin (PNOC) by microarray and immunohistochemistry

A. Donson, N. Foreman, S. Rush, 2012, Pediatric blood & cancer.

A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy with Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells.

M. Wempe, V. Amani, R. Vibhakar, 2016, ACS chemical biology.

Radiation-induced Glioblastoma Multiforme in Children Treated for Medulloblastoma With Characteristics of Both Medulloblastoma and Glioblastoma Multiforme

Amy A. Smith, J. Madden, A. Donson, 2010, Journal of pediatric hematology/oncology.

A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups

T. Jacques, D. Ellison, R. Grundy, 2020, Pediatric blood & cancer.

Predicting which children are at risk for ependymoma relapse

A. Donson, N. Foreman, M. Handler, 2006, Journal of Neuro-Oncology.

Unique Molecular Characteristics of Radiation-Induced Glioblastoma

B. Kleinschmidt-DeMasters, J. Madden, A. Donson, 2007, Journal of neuropathology and experimental neurology.

Paired Overexpression of ErbB3 and Sox10 in Pilocytic Astrocytoma

A. Anwar, B. Kleinschmidt-DeMasters, A. Donson, 2006, Journal of neuropathology and experimental neurology.

Identification of targets for rational pharmacological therapy in childhood craniopharyngioma

J. Johnston, Karun K. Rao, V. Amani, 2015, Acta Neuropathologica Communications.

Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma

M. Souweidane, J. Johnston, T. Jacques, 2017, Journal of neuropathology and experimental neurology.

PARP1 expression in pediatric central nervous system tumors

A. Donson, N. Foreman, Arthur K Liu, 2009, Pediatric blood & cancer.

Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic images

Gerald Grant, Elizabeth Tyler-Kabara, George Jallo, 2020, Scientific Reports.

Radiation-induced meningiomas: clinical, cytogenetic, and microarray features

K. Lillehei, B. Kleinschmidt-DeMasters, A. Donson, 2008, Acta Neuropathologica.

Claudin 6 Is a Positive Marker for Atypical Teratoid/Rhabdoid Tumors

B. Kleinschmidt-DeMasters, A. Donson, N. Foreman, 2010, Brain pathology.

Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma

Eric W Prince, V. Amani, R. Vibhakar, 2016, BMC Cancer.

Spatial transcriptomic analysis of childhood ependymoma implicates unresolved wound healing as a driver of tumor progression

K. Riemondy, V. Amani, S. Mitra, 2022, bioRxiv.

MODL-31. Novel in vivo models of post-radiation recurrent pediatric high-grade glioma show increased susceptibility to MAPK inhibition

S. Karam, A. Donson, A. Knox, 2022, Neuro-Oncology.

Protein kinase C zeta isoform is critical for proliferation in human glioblastoma cell lines.

F. Gamboni-Robertson, A. Donson, N. Foreman, 2000, Journal of neuro-oncology.

Cross-species genomics reveals oncogenic dependencies in ZFTA/C11orf95 fusion-positive supratentorial ependymomas.

David T. W. Jones, G. Reifenberger, M. Kool, 2021, Cancer discovery.

Identification of targets for rational pharmacological therapy in childhood craniopharyngioma

J. Johnston, Karun K. Rao, B. Kleinschmidt-DeMasters, 2015, Acta neuropathologica communications.

Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas

F. Saggioro, C. Scrideli, L. Tone, 2023, Cancer Gene Therapy.

Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma

S. Karam, C. Albanese, R. Vibhakar, 2017, Cancer Cell International.

Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature

David C. Jones, P. Varlet, D. Schrimpf, 2023, npj Precision Oncology.

Myxoid glioneuronal tumor, PDGFRA p.K385L‐mutant, arising in midbrain tectum with multifocal CSF dissemination

A. Donson, A. Gilani, J. Chiang, 2021, Brain pathology.

Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma

Eric W Prince, V. Amani, R. Vibhakar, 2017, Oncology reports.

Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas

Mariella G. Filbin, A. Chinnaiyan, M. Kool, 2021, Science Translational Medicine.

DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

Noah E. Berlow, Elaine C. Huang, T. Lagerweij, 2012 .

Rare nerve lesions of non-nerve sheath origin: a 17-year retrospective series.

T. Strom, K. Lillehei, B. Kleinschmidt-DeMasters, 2009, Archives of pathology & laboratory medicine.

PDGFB:APOBEC3C fusion in congenital diffuse high-grade glioma of the brainstem.

A. Donson, N. Foreman, B. O’neill, 2022, Journal of neuropathology and experimental neurology.

Tumor vaccination for malignant brain tumors

A. Donson, N. Foreman, 2010, Pediatric Blood & Cancer.

Single-Cell RNAseq of Childhood Ependymoma Reveals Distinct Neoplastic Cell Subpopulations that Impact Etiology, Molecular Classification and Outcome

Eric W Prince, Kenneth L. Jones, J. Hesselberth, 2020, Social Science Research Network.

Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma

Eric W Prince, R. Grundy, K. Riemondy, 2023, iScience.

EPEN-09. RNA-SEQ ANALYSIS OF RECURRENT PAEDIATRIC EPENDYMOMAS REVEALS IMMUNOLOGICAL CHANGES SPECIFIC TO MOLECULAR SUBGROUPS

T. Jacques, R. Grundy, A. Donson, 2018, Neuro-Oncology.

Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of Childhood

Eric W Prince, V. Amani, R. Vibhakar, 2017, Journal of neuropathology and experimental neurology.

Pediatric Brainstem Gangliogliomas Show BRAFV600E Mutation in a High Percentage of Cases

D. Aisner, B. Kleinschmidt-DeMasters, Amy A. Smith, 2014, Brain Pathology.

Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity

A. Thorburn, A. Donson, N. Foreman, 2010, Molecular Cancer Therapeutics.

Diffuse intrinsic pontine tumors: a study of primitive neuroectodermal tumors versus the more common diffuse intrinsic pontine gliomas.

A. Donson, N. Foreman, P. Jedlicka, 2012, Journal of neurosurgery. Pediatrics.

Inhibition of Aurora Kinase A enhances chemosensitivity of medulloblastoma cell lines

A. Donson, N. Foreman, Rong Fan, 2010, Pediatric blood & cancer.

Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targets

Eric W Prince, M. Souweidane, D. Limbrick, 2020, Acta Neuropathologica Communications.

Pediatric brainstem gangliogliomas show overexpression of neuropeptide prepronociceptin (PNOC) by microarray and immunohistochemistry

B. Kleinschmidt-DeMasters, A. Donson, D. Birks, 2012, Pediatric blood & cancer.

Preclinical high‐dose acetaminophen with N‐acetylcysteine rescue enhances the efficacy of cisplatin chemotherapy in atypical teratoid rhabdoid tumors

E. Neuwelt, V. Amani, A. Donson, 2014, Pediatric blood & cancer.

Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes

B. Kleinschmidt-DeMasters, A. Donson, N. Foreman, 2013, Pediatric blood & cancer.

Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas

K. Riemondy, V. Amani, A. Donson, 2023, Acta Neuropathologica Communications.

Aurora kinase A as a rational target for therapy in glioblastoma.

A. Donson, N. Foreman, M. Handler, 2010, Journal of neurosurgery. Pediatrics.

Glycation of Glutamate Cysteine Ligase by 2-Deoxy-d-Ribose and its Potential Impact on Chemoresistance in Glioblastoma

J. Kepa, D. Petersen, A. Donson, 2013, Neurochemical Research.